Sanofi Rises 3% on Q1 Beats, CEO Coronavirus Vaccine Comments
Sanofi Rises 3% on Q1 Beats, CEO Coronavirus Vaccine Comments 1Sanofi (NASDAQ:SNY) ended the week on an up note, buoyed by an encouraging quarterly earnings release and market-pleasing remarks its CEO made about potential SARS-CoV-2 coronavirus vaccine manufacturing.
News story posted on 2020-04-27T06:49:00.0000000Z